Funded Research

Our research efforts center on understanding individual- and community-level factors that influence health behavior choices and developing ways to encourage positive behavior change.

12/19/17
In the last decade, the HIV prevention field has witnessed a distinct shift, with emphasis on biomedical strategies to supplement behavioral interventions. One of these approaches is the use of preexposure prophylaxis (PrEP), co-formulated antiretroviral medications taken to reduce the risk of HIV infection.
6/19/14
This study will develop and initially test an intervention designed to help young adults who regularly use marijuana to reduce their intake.
6/19/14
The Global Adult Tobacco Survey (GATS) was created by major national and international health agencies to improve the ability of countries to design, implement and evaluate anti-tobacco efforts.
6/19/14
People sometimes don’t know their risk for health problems. This study examines how not knowing your risk affects engaging in health behaviors to prevent health problems.
6/19/14
Sleep disturbances are cardinal features of veterans with post-traumatic stress disorder. This randomized cross-over trial will examine two treatment options for sleep apnea among veterans.
12/2/15
Operation: SAFETY is a longitudinal research study which will examine the health and well-being of U.S. Army Reserve/National Guard Soldiers and their partners.
6/24/15
Despite the commonly held belief that marijuana suppresses aggression, many cross-sectional and longitudinal surveys find positive associations between marijuana use and intimate partner violence (IPV).
12/19/17
The prevention of HIV acquisition has been transformed over the last decade with the introduction of pre-exposure prophylaxis (PrEP), in which at-risk HIV uninfected individuals take antiretroviral medications daily to prevent infection. 
12/19/17
To maximize its prevention potential, the public health impact of pre-exposure prophylaxis (PrEP) requires an approach that will lead to: 1) large-scale adoption among eligible populations and 2) identification of current gaps among prescribers.